About Leiutis Pharmaceuticals Private Limited
Data last updated:
Leiutis Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2012.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100AP2012PTC078351. Its GSTIN is 36AACCL1579N1Z1 (Telangana). The company held 2 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹7 Cr and a paid-up capital of ₹6.9 Cr.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2020, the company reported a revenue of ₹16.75 Cr, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹1.79 Cr (net margin 10.7%) and EBITDA of ₹7.95 Cr (EBITDA margin 47.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The company has about 67 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.37 Cr and satisfied charges of ₹3.07 Cr on record. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹15.29 Cr; the latest was in May 2013. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Anra Pharmaceuticals Private Limited with revenue of ₹16.84 Cr.
The last known website on record is leiutis.com.
Company details
Contact details
Leiutis Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is leiutis.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No – 23 4th & 5th Floors Vsr Complex Technocrafts Industrial Estate 1st Phase, Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Leiutis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Leiutis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Leiutis Pharmaceuticals Private Limited, buy the company report.
Financials of Leiutis Pharmaceuticals Private Limited
FY 2020 filings availableLeiutis Pharmaceuticals Private Limited reported revenue of ₹16.75 Cr (up 62% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years, including 62% growth in the latest year. EBITDA rose 201% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹16.75 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.5% | ||||
| Net Profit Margin | 10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Leiutis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Leiutis Pharmaceuticals Private Limited
Leiutis Pharmaceuticals has 5 former directors on record and no current directors listed.
Peer comparison
Leiutis Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anra Pharmaceuticals Private Limited | ₹16.84 Cr (FY 2025) | 74.0% | Vellaripatti, Tamil Nadu, India | |||
| MVL Medisynth Private Limited | ₹16.78 Cr (FY 2024) | 1.0% | Solapur North, Maharashtra, India | |||
| Leiutis Pharmaceuticals Private Limitedthis company | ₹16.75 Cr (FY 2020) | ₹1.79 Cr | 10.7% | 62.0% | 67 | Hyderabad, Telangana, India |
| Salius Pharma Private Limited | ₹16.74 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| Merlin Pharma Private Limited | ₹16.74 Cr (FY 2024) | 24.0% | Mumbai, Maharashtra, India | |||
| Surien Pharmaceuticals Private Limited | ₹16.68 Cr (FY 2025) | -18.0% | Chennai, Tamil Nadu, India | |||
| Oasis Laboratories Pvt Ltd | ₹16.68 Cr (FY 2025) | -1.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Leiutis Pharmaceuticals Private Limited, buy the company report.
Auditor
Leiutis Pharmaceuticals Private Limited is audited by V S P N & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V S P N & CO | FY 2020 | 008178S |
Shareholding
The shareholding of Leiutis Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Leiutis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2012 | 100929147 | Ecl Finance Limited | ₹3.37 Cr | Open | |
| 13 Apr 2018 | 100180623 | Others | ₹2 Lakh | Satisfied | |
| 04 Sep 2017 | 100121884 | Others | ₹34,500 | Satisfied | |
| 17 Mar 2015 | 10573614 | Others | ₹2.55 Cr | Satisfied | |
| 27 Oct 2012 | 10387721 | Reliance Capital Ltd | ₹50 Lakh | Satisfied |
To see the full charge records of Leiutis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Leiutis Pharmaceuticals Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹15.29 Cr; the latest was in May 2013.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2013 | Funding round | ₹3.24 Cr | Investors: 1575773 Ontario Inc |
| Dec 2012 | Funding round | ₹12.05 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Leiutis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Leiutis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Leiutis Pharmaceuticals Private Limited has a workforce of 67 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Leiutis Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCL1579N1Z1 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Leiutis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Leiutis Pharmaceuticals Private Limited has 5 board changes on record since 2021: 0 appointments and 5 cessations. The latest: Chandra Shekhar Kocherlakota ceased to be Director on 16 May 2021.
6 earlier events are in the company report.
Frequently asked questions
Leiutis Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Leiutis Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2012 and is registered under CIN U73100AP2012PTC078351. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Leiutis Pharmaceuticals is U73100AP2012PTC078351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leiutis Pharmaceuticals was incorporated on 02 January 2012. It is registered with the Registrar of Companies, Hyderabad.
Leiutis Pharmaceuticals can be reached through the website leiutis.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Leiutis Pharmaceuticals is at Plot No – 23 4th & 5th Floors Vsr Complex Technocrafts Industrial Estate 1st Phase, Balanagar, Hyderabad, Telangana, India – 500037.
The latest financial statements of Leiutis Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Leiutis Pharmaceuticals is 36AACCL1579N1Z1, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
Leiutis Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Leiutis Pharmaceuticals has 2 deals on record (2 funding rounds), with disclosed funding of ₹15.29 Cr; the latest was in May 2013.
The peers of Leiutis Pharmaceuticals by revenue are Anra Pharmaceuticals Private Limited, MVL Medisynth Private Limited, Salius Pharma Private Limited, Merlin Pharma Private Limited, Surien Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).